PRIMARY STUDY
Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human sepsis?
Key Findings: Researchers propose BCP administration as novel treatment to reduce hyper-inflammation in human sepsis.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Canada, Mexico
Year of Pub: 2018
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Receptors Studied: CB2
Citation: Meza A and Lehmann C. Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?. Med Hypotheses. 2018; 110:68-70. doi: 10.1016/j.mehy.2017.10.025
Authors: Meza A, Lehmann C
